Physician
Family Medicine
Dr. Mark J. Elder, DO
|
|
Give Review
Mark J. Elder, DO works in the field of Family Medicine. Mark Elder is a published doctor and has 76 publications published. The lastest was: 'Primary choroidal malignant melanoma occurring in a New Zealand Maori.' Mark Elder accepts Medicare payments and is listed with Medicare.gov.
Publications
- Uptake of the Perinatal Society of Australia and New Zealand perinatal mortality audit guideline.
- Topical mitomycin C for the local treatment of a primary diffuse large B-cell lymphoma of the palpebral conjunctiva.
- Dietary supplement use in the prevention of age-related macular degeneration progression.
- [Foodborne disease outbreak in El Huecú community, province of Neuquén].
- The New Zealand ophthalmology workforce 2008.
- The fourth New Zealand cataract and refractive surgery survey: 2007.
- Does observer bias contribute to variations in the rate of retinopathy of prematurity between centres?
- Medical treatment of cataract.
- Unplanned overnight hospital admission after strabismus surgery.
- Early paracentral visual field loss in patients taking hydroxychloroquine.
- New Zealand cataract and refractive surgery survey 2004.
- Surgical masks may reduce serious postoperative cataract complications.
- Uveitis, drugs, and the HLAB27 antigen.
- New Zealand experience of I125 brachytherapy for choroidal melanoma.
- A systematic review of the applicability and efficacy of eye exercises.
- Clear lens extraction for the treatment of persistent accommodative spasm after head trauma.
- Globe rupture following penetrating keratoplasty: how often, why, and what can we do to prevent it?
- A fast system for reporting the Farnsworth-Munsell 100-hue colour vision test.
- An eye for fatigation.
- What patients want to know before they have cataract surgery.
- Influence of axial length of normal eyes on PERG.
- Unilateral versus bilateral medial rectus recession.
- Bilateral ptosis caused by localized superficial eyelid amyloidosis.
- The New Zealand cataract and refractive surgery survey 2001.
- A comparison of two patient-friendly ERG electrodes.
- Predicting the refractive outcome after cataract surgery: the comparison of different IOLs and SRK-II v SRK-T.
- The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators.
- The latanoprost monotherapy survey in New Zealand, 2000.
- The early complications of cataract surgery: is routine review of patients 1 week after cataract extraction necessary?
- Warfarin therapy and cataract surgery.
- Cyanoacrylate glue for corneal perforations: a description of a surgical technique and a review of the literature.
- The New Zealand cataract and refractive surgery survey 1997/1998.
- Visual, refractive, and subjective outcomes after photorefractive keratectomy for myopia of 6 to 10 diopters using the Nidek laser.
- Primary choroidal malignant melanoma occurring in a New Zealand Maori.
- The conundrum of endophthalmitis.
- Intermediate filament expression by normal and diseased human corneal epithelium.
- Intraocular lens materials and styles: a review.
- Acute ocular methanol toxicity: clinical and electrophysiological features.
- Conjunctival fibrosis in ocular cicatricial pemphigoid--the role of cytokines.
- Anatomy and physiology of eyelash follicles: relevance to lash ablation procedures.
- The role of cytokines in chronic progressive conjunctival cicatrisation.
- The immunologic target: antigenic aspects of basement membranes.
- Topical and systemic immunosuppression for chronic progressive conjunctival cicatrisation.
- Keratopathy in chronic progressive conjunctival cicatrisation.
- Introduction to cicatrising conjunctivitis.
- Lid surgery: the management of cicatricial entropion and trichiasis.
- The eyelid sequelae of chronic progressive conjunctival cicatrisation.
- General considerations in the management of chronic progressive conjunctival cicatrisation.
- Monitoring of activity and progression in cicatrising conjunctivitis.
- The management of ocular surface disease.
- Sulphapyridine--a new agent for the treatment of ocular cicatricial pemphigoid.
- Apparent accommodation and depth of field in pseudophakia.
- Immunocompromised patients, herpes zoster and acyclovir.
- Biofilm formation in infectious crystalline keratopathy due to Candida albicans.
- Progression of disease in ocular cicatricial pemphigoid.
- Anterior lamellar repositioning and grey line split for upper lid entropion in ocular cicatricial pemphigoid.
- Inferior retractor plication surgery for lower lid entropion with trichiasis in ocular cicatricial pemphigoid.
- Diagnosis and management of an occult cyclodialysis cleft.
- Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid.
- Biofilm-related infections in ophthalmology.
- Cryotherapy for trichiasis in ocular cicatricial pemphigoid.
- The value of biopsies in the evaluation of chronic progressive conjunctival cicatrisation.
- Occlusion therapy for strabismic amblyopia.
- Recurrent corneal erosion in cystinosis.
- Aetiology of severe visual impairment and blindness in microphthalmos.
- The immunological features and pathophysiology of ocular cicatricial pemphigoid.
- Leber congenital amaurosis and its association with keratoconus and keratoglobus.
- Congenital glaucoma in the West Bank and Gaza Strip.
- Mersilene mesh and fascia lata in brow suspension: a comparative study.
- Penetrating eye injuries in children of the West Bank and Gaza strip.
- Paediatric dacryocystorhinostomy.
- Diazepam and its effects on visual fields.
- A clinicopathological study of loop recession in strabismus.
- Five-year follow-up of clear cornea trabeculectomy.
- Bone implants after enucleation.
Schools
Kansas City Univ Of Medicine Bioscience College Of Osteopathic Medicine
Cox Fam Prac Res
Doctors Specialties
- Family Medicine
Accepted Insurances
- Choice Plus POS II
- AvMed
- Blue Card PPO
- Dental Blue 100/200/300
- Blue Care HMO
- Blue Select
- BlueDental Choice
- NetworkBlue
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- Employer Group Open Access HMO
- Humana
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Neighborhood Health Partnership
- Options PPO
- United Healthcare
- WellCare
Education
-
Kansas City University of Medicine and Biosciences
Drug Facts
| NPI NUMBER | 1477559409 | |
| NPPES Provider LastName | ELDER | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 325701014 | |
| NPPES Provider State | FL | |
| Specialty Description | Emergency Medicine | |
| Total Claim Count | 22771.0 | |
| Distinct Opioid Count | 11.0 | |
| Opioid Claim Count | 2615.0 | |
| Percent Opioid Claims | 11.48 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1477559409 |
| Last Name Of The Provider | ELDER |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
|
Dr. Mark Josephson, MD |
|
|
Dr. William J. Whibbs, MD |
|
|
Dr. Dennis M. Hurtado, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Monica K. Nall, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan S. Leibig, MD |
|
|
Dr. Keith A. Knigge, DO |
|
|
Dr. Logan T. Porter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ann M. Kopelson, MD |
|
|
Dr. Bach-Uyen T. Le Thi, MD |
|
|
Dr. Elias I. Banuelos, MD
This Doctor is OpenDoctor Recommended.
|